Publication | Open Access

Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

OncologyMedicineProton Pump InhibitorsPharmacotherapyAnti-cancer AgentCancer TreatmentPost Hoc AnalysisPharmacologyLung Cancer